Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Trends in Single-Use Mixing Technologies and Insight into Pall and Lonza Ibex® Solutions
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
View All Featured ArticlesHeadline News
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Pasritamig combination delivers 73% PSA response rate in advanced prostate cancer Phase I study
Regeneron CIDEBsiRNA delivers up to 80% liver fat reduction in early MASLD study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Mechanistic Modelling in Early Stage Chromatography Process Development for Improving Process Efficiency and Productivity
Presented by Yuyi Shen, Associate Director, Process Development and Manufacturing at Bolt Therapeutics and Nick Whitelock, Business Development Manager at GoSilico GmbH
19th April 2021
Chemical and Physical Transformation Monitoring by Raman and IR Spectroscopies in Pharmaceutical Development
Presented by John Wasylyk, Senior Principal Scientist at Bristol-Myers Squibb and Karen Esmonde-White, Senior Marcom Specialist at Kaiser Optical Systems Inc.
01st July 2019
End User Perspective on Setting in-Process Endotoxin Limits
Presented by Dr Friedrich von Wintzingerode, Roche/Genentech
15th May 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
